European Union - English - EMA (European Medicines Agency)

biocodex - stiripentol - myoclonic epilepsy, juvenile - antiepileptics, - diacomit is indicated for use in conjunction with clobazam and valproate as adjunctive therapy of refractory generalized tonic-clonic seizures in patients with severe myoclonic epilepsy in infancy (smei, dravet's syndrome) whose seizures are not adequately controlled with clobazam and valproate.

Canada - English - Health Canada

biocodex sas - stiripentol - capsule - 250mg - stiripentol 250mg - miscellaneous anticonvulsants

Canada - English - Health Canada

biocodex sas - stiripentol - capsule - 500mg - stiripentol 500mg - miscellaneous anticonvulsants

Canada - English - Health Canada

biocodex sas - stiripentol - powder for suspension - 250mg - stiripentol 250mg - miscellaneous anticonvulsants

Canada - English - Health Canada

biocodex sas - stiripentol - powder for suspension - 500mg - stiripentol 500mg - miscellaneous anticonvulsants

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alan pharmaceuticals - stiripentol - capsule - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alan pharmaceuticals - stiripentol - powder - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alan pharmaceuticals - stiripentol - capsule - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alan pharmaceuticals - stiripentol - powder - 500mg